Geoffrey Woo is co-founder and CEO of HVMN. Geoffrey earned
his BS in Computer Science from Stanford University
with Honors and Distinction and specialized in Distributed
Systems and Information Theory.
In early 2014, Geoffrey began conducting his own n=1 experiments to
optimize his cognitive, physical, and metabolic biomarkers through
a systems approach. HVMN started as Nootrobox, a project he started
with Michael Brandt to formalize and operationalize the production of
nootropic combinations that they were sourcing and producing themselves.
Within the first few months of operation, Nootrobox was grossing
over six-figures in revenues per month. Geoffrey published a series
of articles on TechCrunch advocating smart regulation for human
enhancement technologies and humans as a platform and innovation
and built a following within Silicon Valley.
In early 2016, Geoffrey started experimenting with intermittent
fasting to activate metabolic pathways associated with longevity
and cognitive function. To make the science and physiology behind
the benefits of fasting more accessible, Geoffrey started WeFast,
one of the largest online intermittent fasting communities,
and became a widely cited spokesperson for intermittent fasting in the media.
Realizing that ketosis was a primary driver behind why fasting works,
Geoffrey began investigating ways to elevate blood ketones.
Geoffrey forged a partnership with Professor Kieran Clarke of the
University of Oxford to develop HVMN Ketone Ester, the world’s first
ketone ester drink, based on Prof. Clarke and Dr. Richard Veech’s
(NIH) seminal work on ketone esters and exogenous ketones.
As part of the expansion of scope of Nootrobox,
the company was renamed HVMN in 2017.
Geoffrey is a serial entrepreneur. He previously was CEO and co-founder
of Glassmap Inc., a software technology company backed by
YCombinator, a top venture capital group, and acquired by Groupon ($GRPN).